Michael J. Fisch, MD, MPH, FACP, FAAHPM, FASCO
Department of General Oncology, Division of Cancer Medicine
About Dr. Michael J. Fisch
Dr. Fisch is clinical professor (part-time) at the University of Texas MD Anderson Cancer Center in Houston. His faculty career at MD Anderson began in the Department of Palliative Care and Rehabilitation in 1999. He then led the MD Anderson Community Clinical Oncology Program (CCOP) Research Base and subsequently served as the founding chair of the Department of General Oncology. In the latter role, Dr. Fisch led a group of clinical faculty involved in clinical and basic research and the management of patients in community and academic settings. Since 2015, Dr. Fisch is also employed by AIM Specialty Health, a subsidiary of Anthem, Inc. In this role, he serves as Senior Medical Director of Medical Oncology Programs and Genetics and he is involved in implementing clinical solutions for health plans who are trying to promote appropriate, safe, and affordable care.
Throughout his career, Dr. Fisch has held numerous national service roles. Currently, he is a co-chair of the SWOG Symptom Control and Quality of Life Committee and a member of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). From 2007 to 2014, he co-chaired the NCI Symptom Management and Quality of Life Committee. He also served as chair of the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network (ECOG-ACRIN) Symptom Science and Treatment Toxicity Committee, the SWOG Social Media Working Group, and the first American Society of Clinical Oncology (ASCO) Palliative Care in Oncology Symposium.
Dr. Fisch completed his undergraduate, medical school, and internal medicine training at the University of Virginia and his hematology/oncology fellowship training at Indiana University. He also received his Master’s in Public Health at Indiana University. He is board-certified in medical oncology, internal medicine, and hospice and palliative medicine, and has been honored by election to fellowship by the professional societies in each of these disciplines.
Present Title & Affiliation
Primary Appointment
Senior National Medical Director, Department of Oncology and Genetics, AIM Specialty Health Inc, Chicago, IL
Dual/Joint/Adjunct Appointment
Clinical Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1997 | Indiana University, Bloomington, IN, USA, MPH, Health Education |
| 1990 | University of Virginia, Charlottesville, VA, USA, MD, Clinical Medicine |
Board Certifications
| 2003 | American Board of Hospice and Palliative Medicine |
| 1997 | Medical Oncology |
| 1993 | Internal Medicine |
Experience & Service
Academic Appointments
Clinical Specialist, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2019
National Medical Director, Division of Medical Oncology and Genetics, AIM Specialty Health, Chicago, IL, 2015 - 2022
Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2015
Chair, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2015
Institutional Committee Activities
Co-Chair, Patient Experience Steering Committee, 2014 - 2015
Member, Clinical Faculty Review Committee, 2013 - 2015
Member, Medical Quality Planning Committee, 2013 - 2015
Member, Division of Internal Medicine (DoIM) Division Head Search Committee, 2013 - 2014
Member, Patient Experience Steering Committee, 2012 - 2015
Member, Physician Relations Faculty Advisory Board, 2012 - 2015
Honors & Awards
| 2019 | Vicente Valero LBJ Clinician Educator of the Year |
Selected Publications
Peer-Reviewed Articles
- Unger JM, Vaidya R, Albain KS, LeBlanc M, Minasian LM, Gotay CC, Henry NL, Fisch MJ, Lee SM, Blanke CD, Hershman DL. Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials. J Clin Oncol 40(13):JCO2102377, 2022. e-Pub 2022. PMID: 35119908.
- Gunturu KS, Pham TT, Shambhu S, Fisch MJ, Barron JJ, Debono D. Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients. Support Care Cancer 30(5):4019-4026, 2022. e-Pub 2022. PMID: 35064328.
- Whisenant MS, Williams LA, Mendoza T, Cleeland C, Chen TH, Fisch MJ, Shi Q. Identification of Breast Cancer Survivors With High Symptom Burden. Cancer Nurs 45(4):253-261, 2022. e-Pub 2021. PMID: 34608052.
- Henry NL, Unger JM, Till C, Crew KD, Fisch MJ, Hershman DL. Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor-Associated Musculoskeletal Symptoms. JNCI Cancer Spectr 5(6), 2021. e-Pub 2021. PMID: 34901744.
- Van Poznak CH, Unger JM, Darke AK, Moinpour C, Bagramian RA, Schubert MM, Hansen LK, Floyd JD, Dakhil SR, Lew DL, Wade JL, Fisch MJ, Henry NL, Hershman DL, Gralow J. Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer. JAMA Oncol 7(2):246-254, 2021. PMID: 33331905.
- Stephenson JJ, Gable JC, Zincavage R, Price GL, Churchill C, Zhu E, Stenger K, Singhal M, Nepal B, Grabner M, Fisch MJ, Debono D, Geschwender AR, Cuyun Carter G. Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study. Patient Prefer Adherence 15:2417-2429, 2021. e-Pub 2021. PMID: 34764640.
- Bekelman JE, Gupta A, Fishman E, Debono D, Fisch MJ, Liu Y, Sylwestrzak G, Barron J, Navathe AS. Association Between a National Insurer's Pay-for-Performance Program for Oncology and Changes in Prescribing of Evidence-Based Cancer Drugs and Spending. J Clin Oncol 38(34):4055-4063, 2020. e-Pub 2020. PMID: 33021865.
- Alvarez-Cardona JA, Zhang KW, Mitchell JD, Zaha VG, Fisch MJ, Lenihan DJ. Cardiac Biomarkers During Cancer Therapy: Practical Applications for Cardio-Oncology. JACC CardioOncol 2(5):791-794, 2020. e-Pub 2020. PMID: 34396295.
- Shi Q, Lee JW, Wang XS, Fisch MJ, Chang VT, Wagner L, Cleeland CS. Testing Symptom Severity Thresholds and Potential Alerts for Clinical Intervention in Patients With Cancer Undergoing Chemotherapy. JCO Oncol Pract 16(9):e893-e901, 2020. e-Pub 2020. PMID: 32369412.
- Fishman E, Fisch MJ, Liu Y, Barron JJ, Nguyen A, Sylwestrzak G. Use of Optimal Evidence-Based Anticancer Drug Regimens in Physician Offices Versus Hospital Outpatient Facilities. JCO Oncol Pract 16(8):e797-e806, 2020. e-Pub 2020. PMID: 32155109.
- Wong SF, Unger JM, Wade JL, Wagner LI, Lacouture ME, Humphries KC, Moseley A, Arnold K, Velasco MR, Floyd JD, Esparaz BT, Barzi A, Lenz HJ, Koczywas M, Dakhil S, Burton GV, Fisch MJ, Henry NL, Hershman DL, Moinpour CM. A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013. J Patient Rep Outcomes 4(1):54, 2020. e-Pub 2020. PMID: 32642992.
- Hunter JJ, Maunder RG, Sui D, Esplen MJ, Chaoul A, Fisch MJ, Bassett RL, Harden-Harrison MM, Lagrone L, Wong L, Baez-Diaz L, Cohen L. A randomized trial of nurse-administered behavioral interventions to manage anticipatory nausea and vomiting in chemotherapy. Cancer Med 9(5):1733-1740, 2020. e-Pub 2020. PMID: 31957269.
- Fisch MJ, Grabner M, Mytelka DS, Raval AD, Bowman L, Kern DM, Churchill C, Singer J, Wetmore S, Barron J, Eleff M. Occurrence and Characteristics of Hospitalizations During First-Line Chemotherapy Among Individuals with Metastatic Colorectal Cancer. Cancer Manag Res 12:1535-1541, 2020. e-Pub 2020. PMID: 32184658.
- Katz MS, Anderson PF, Thompson MA, Salmi L, Freeman-Daily J, Utengen A, Dizon DS, Blotner C, Cooke DT, Sparacio D, Staley AC, Fisch MJ, Young C, Attai DJ. Organizing Online Health Content: Developing Hashtag Collections for Healthier Internet-Based People and Communities. JCO Clin Cancer Inform 3:1-10, 2019. PMID: 31251658.
- Henry NL, Unger JM, Till C, Schott AF, Crew KD, Lew DL, Fisch MJ, Moinpour CM, Wade JL, Hershman DL. Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202. Cancer 125(12):2123-2129, 2019. e-Pub 2019. PMID: 30861098.
- Hwang JP, Huang D, Vierling JM, Suarez-Almazor ME, Shih YT, Chavez-MacGregor M, Duan Z, Giordano SH, Hershman DL, Fisch MJ, Cantor SB. Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. JCO Clin Cancer Inform 3:1-12, 2019. PMID: 30892921.
- Fishman E, Barron J, Liu Y, Gautam S, Bekelman JE, Navathe AS, Fisch MJ, Nguyen A, Sylwestrzak G. Using claims data to attribute patients with breast, lung, or colorectal cancer to prescribing oncologists. Pragmat Obs Res 10:15-22, 2019. e-Pub 2019. PMID: 31015772.
- Shen S, Unger JM, Crew KD, Till C, Greenlee H, Gralow J, Dakhil SR, Minasian LM, Wade JL, Fisch MJ, Henry NL, Hershman DL. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). Breast Cancer Res Treat 172(3):603-610, 2018. e-Pub 2018. PMID: 30159789.
- Dizon DS, Sedrak MS, Lewis MA, Cook E, Fisch MJ, Klemp JR, Sommers J, Ciccarella A, Gralow J, Lawton W, Nichols C, SWOG Digital Engagement Committee. Incorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOG. JCO Clin Cancer Inform 2:1-8, 2018. PMID: 30652537.
- Hershman DL, Unger JM, Greenlee H, Capodice JL, Lew DL, Darke AK, Kengla AT, Melnik MK, Jorgensen CW, Kreisle WH, Minasian LM, Fisch MJ, Henry NL, Crew KD. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial. JAMA 320(2):167-176, 2018. PMID: 29998338.
- Hershman DL, Unger JM, Crew KD, Till C, Greenlee H, Minasian LM, Moinpour CM, Lew DL, Fehrenbacher L, Wade JL, Wong SF, Fisch MJ, Lynn Henry N, Albain KS. Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715). J Natl Cancer Inst 110(6):669-676, 2018. PMID: 29361042.
- Jones D, Cohen L, Rieber AG, Urbauer D, Fellman B, Fisch MJ, Nazario A. Complementary and Alternative Medicine Use in Minority and Medically Underserved Oncology Patients: Assessment and Implications. Integr Cancer Ther 17(2):371-379, 2018. e-Pub 2017. PMID: 29025275.
- Fisch MJ, McNeill LH, Basen-Engquist KM. Helping Colorectal Cancer Survivors Benefit From Changing Lifestyle Behaviors: Implementation Science and Private Industry Collaboration to the Rescue. JAMA Oncol 4(6):777-778, 2018. PMID: 29801068.
- Wong YN, Manola J, Hudes GR, Roth BJ, Moul JW, Barsevick AM, Scher RM, Volk MJ, Vaughn DJ, Williams SD, Fisch MJ, Cella D, Carducci MA, Wilding G. Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial. Clin Genitourin Cancer 16(2):e315-e322, 2018. e-Pub 2017. PMID: 29173976.
- Hwang JP, Lok AS, Fisch MJ, Cantor SB, Barbo A, Lin HY, Foreman JT, Vierling JM, Torres HA, Granwehr BP, Miller E, Eng C, Simon GR, Ahmed S, Ferrajoli A, Romaguera J, Suarez-Almazor ME. Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study. J Clin Oncol:JCO2017756387. e-Pub 2018. PMID: 29447061.
- Henry NL, Unger JM, Schott AF, Fehrenbacher L, Flynn PJ, Prow DM, Sharer CW, Burton GV, Kuzma CS, Moseley A, Lew DL, Fisch MJ, Moinpour CM, Hershman DL, Wade JL. Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202. J Clin Oncol 36(4):326-332, 2018. e-Pub 2017. PMID: 29136387.
- Agiro A, DeVries A, Malin J, Fisch MJ. Real-World Impact of a Decision Support Tool on Colony-Stimulating Factor Use and Chemotherapy-Induced Febrile Neutropenia Among Patients With Breast Cancer. J Natl Compr Canc Netw 16(2):162-169, 2018. PMID: 29439177.
- Ritchie CS, Zhao F, Patel K, Manola J, Kvale EA, Snyder CF, Fisch MJ. Association between patients' perception of the comorbidity burden and symptoms in outpatients with common solid tumors. Cancer 123(19):3835-3842, 2017. e-Pub 2017. PMID: 28608952.
- Attai DJ, Anderson PF, Fisch MJ, Graham DL, Katz MS, Kesselheim J, Markham MJ, Pennell NA, Sedrak MS, Thompson MA, Utengen A, Dizon DS, Collaboration for Outcomes on Social Media in Oncology (COSMO). Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine. Semin Hematol 54(4):198-204, 2017. e-Pub 2017. PMID: 29153081.
- Hwang JP, Suarez-Almazor ME, Cantor SB, Barbo A, Lin HY, Ahmed S, Chavez-MacGregor M, Donato-Santana C, Eng C, Ferrajoli A, Fisch MJ, McLaughlin P, Simon GR, Rondon G, Shpall EJ, Lok AS. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy. Cancer 123(17):3367-3376, 2017. e-Pub 2017. PMID: 28518219.
- Wells QS, Veatch OJ, Fessel JP, Joon AY, Levinson RT, Mosley JD, Held EP, Lindsay CS, Shaffer CM, Weeke PE, Glazer AM, Bersell KR, Van Driest SL, Karnes JH, Blair MA, Lagrone LW, Su YR, Bowton EA, Feng Z, Ky B, Lenihan DJ, Fisch MJ, Denny JC, Roden DM. Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults. Pharmacogenet Genomics 27(7):247-254, 2017. PMID: 28542097.
- Elsayem AF, Fisch MJ. Neuroleptics for Delirium: More Research Is Needed. JAMA Intern Med 177(7):1053-1054, 2017. PMID: 28672353.
- Chandwani KD, Zhao F, Morrow GR, Deshields TL, Minasian LM, Manola J, Fisch MJ. Lack of Patient-Clinician Concordance in Cancer Patients: Its Relation With Patient Variables. J Pain Symptom Manage 53(6):988-998, 2017. e-Pub 2017. PMID: 28185892.
- Sedrak MS, Dizon DS, Anderson PF, Fisch MJ, Graham DL, Katz MS, Kesselheim JC, Miller RS, Thompson MA, Utengen A, Attai DJ, Collaboration for Outcomes on Social Media in Oncology (COSMO). The emerging role of professional social media use in oncology. Future Oncol 13(15):1281-1285, 2017. e-Pub 2017. PMID: 28589770.
- Adeboyeje G, Agiro A, Malin J, Fisch MJ, DeVries A. Reducing Overuse of Colony-Stimulating Factors in Patients With Lung Cancer Receiving Chemotherapy: Evidence From a Decision Support-Enabled Program. J Oncol Pract 13(4):e337-e345, 2017. e-Pub 2017. PMID: 28260403.
- Narayan HK, Wei W, Feng Z, Lenihan D, Plappert T, Englefield V, Fisch M, Ky B. Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study. Open Heart 4(1):e000524, 2017. e-Pub 2017. PMID: 28123764.
- Rich T, Zhao F, Cruciani RA, Cella D, Manola J, Fisch MJ. Association of fatigue and depression with circulating levels of proinflammatory cytokines and epidermal growth factor receptor ligands: a correlative study of a placebo-controlled fatigue trial. Cancer Manag Res 9:1-10, 2017. e-Pub 2017. PMID: 28203105.
- Kern DM, Barron JJ, Wu B, Ganetsky A, Willey VJ, Quimbo RA, Fisch MJ, Singer J, Nguyen A, Mamtani R. A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data. Pragmat Obs Res 8:149-155, 2017. e-Pub 2017. PMID: 28894396.
- Delgado-Guay MO, Rodriguez-Nunez A, De la Cruz V, Frisbee-Hume S, Williams J, Wu J, Liu D, Fisch MJ, Bruera E. Advanced cancer patients' reported wishes at the end of life: a randomized controlled trial. Support Care Cancer 24(10):4273-81, 2016. e-Pub 2016. PMID: 27165052.
- Fisch MJ, Chang VT. Intended Target of the Centers for Disease Control and Prevention Opioid Guidelines-Reply. JAMA Oncol 2(9):1243-4, 2016. PMID: 27466756.
- Attai DJ, Sedrak MS, Katz MS, Thompson MA, Anderson PF, Kesselheim JC, Fisch MJ, Graham DL, Utengen A, Johnston C, Miller RS, Dizon DS, Collaboration for Outcomes on Social Media in Oncology (COSMO). Social media in cancer care: highlights, challenges & opportunities. Future Oncol 12(13):1549-52, 2016. e-Pub 2016. PMID: 27025657.
- Fisch MJ, Chang VT. Striving for Safe, Effective, Affordable Care for Cancer Survivors With Chronic Pain: Another Kind of Moonshot. JAMA Oncol 2(7):862-4, 2016. PMID: 27054656.
- Lenihan DJ, Hartlage G, DeCara J, Blaes A, Finet JE, Lyon AR, Cornell RF, Moslehi J, Oliveira GH, Murtagh G, Fisch M, Zeevi G, Iakobishvili Z, Witteles R, Patel A, Harrison E, Fradley M, Curigliano G, Lenneman CG, Magalhaes A, Krone R, Porter C, Parasher S, Dent S, Douglas P, Carver J. Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary Specialty. J Card Fail 22(6):465-71, 2016. e-Pub 2016. PMID: 27038642.
- Lenihan DJ, Stevens PL, Massey M, Plana JC, Araujo DM, Fanale MA, Fayad LE, Fisch MJ, Yeh ET. The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study. J Card Fail 22(6):433-8, 2016. e-Pub 2016. PMID: 27079675.
- Spencer CN, Lopez G, Cohen L, Urbauer DL, Hallman DM, Fisch MJ, Parker PA. Nurse and patient characteristics predict communication about complementary and alternative medicine. Cancer 122(10):1552-9, 2016. e-Pub 2016. PMID: 26991683.
- Tevaarwerk AJ, Lee JW, Terhaar A, Sesto ME, Smith ML, Cleeland CS, Fisch MJ. Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study. Cancer 122(3):438-46, 2016. e-Pub 2015. PMID: 26687819.
- Chouhan J, Gupta R, Ensor J, Raghav K, Fogelman D, Wolff RA, Fisch M, Overman MJ. Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction. Cancer Med 5(2):239-47, 2016. e-Pub 2015. PMID: 26714799.
- Fisch MJ, Chung AE, Accordino MK. Using Technology to Improve Cancer Care: Social Media, Wearables, and Electronic Health Records. Am Soc Clin Oncol Educ Book 35:200-8, 2016. PMID: 27249700.
- Hwang JP, Granwehr BP, Torres HA, Suarez-Almazor ME, Giordano TP, Barbo AG, Lin HY, Fisch MJ, Chiao EY. HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center. J Oncol Pract 11(5):384-90, 2015. e-Pub 2015. PMID: 26243649.
- Fisch MJ. Advance Directives: Sometimes Necessary But Rarely Sufficient. JAMA Oncol 1(5):609-10, 2015. PMID: 26181581.
- Anderson KO, Palos GR, Mendoza TR, Cleeland CS, Liao KP, Fisch MJ, Garcia-Gonzalez A, Rieber AG, Nazario LA, Valero V, Hahn KM, Person CL, Payne R. Automated pain intervention for underserved minority women with breast cancer. Cancer 121(11):1882-90, 2015. e-Pub 2015. PMID: 25711974.
- Penas-Prado M, Hess KR, Fisch MJ, Lagrone LW, Groves MD, Levin VA, De Groot JF, Puduvalli VK, Colman H, Volas-Redd G, Giglio P, Conrad CA, Salacz ME, Floyd JD, Loghin ME, Hsu SH, Gonzalez J, Chang EL, Woo SY, Mahajan A, Aldape KD, Yung WK, Gilbert MR, MD Anderson Community Clinical Oncology Program and the Brain Tumor Trials Collaborative. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol 17(2):266-73, 2015. e-Pub 2014. PMID: 25239666.
- Bilen MA, Johnson MM, Mathew P, Pagliaro LC, Araujo JC, Aparicio A, Corn PG, Tannir NM, Wong FC, Fisch MJ, Logothetis CJ, Tu SM. Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer. Cancer 121(1):69-76, 2015. e-Pub 2014. PMID: 25155428.
- Lewis MA, Zhao F, Jones D, Loprinzi CL, Brell J, Weiss M, Fisch MJ. Neuropathic symptoms and their risk factors in medical oncology outpatients with colorectal versus breast, lung or prostate cancer: Results from a prospective multicenter study. J Pain Symptom Manage. e-Pub 2015. PMID: 25596011.
- Parker PA, Urbauer D, Fisch MJ, Fellman B, Hough H, Miller J, Lanzotti V, Whisnant M, Weiss M, Fellenz L, Bury M, Kokx P, Finn K, Daily M, Cohen L. A multi-site, community oncology-based randomized trial of a brief educational intervention to increase communication regarding complementary and alternative medicine. Cancer, 2013. e-Pub 2013. PMID: 23824945.
- Mendoza TR, Zhao F, Cleeland CS, Wagner LI, Patrick-Miller LJ, Fisch MJ. The validity and utility of the M.D. Anderson Symptom Inventory in Patients with Breast Cancer: Evidence from the Symptom Outcomes and Practice Patterns Data from the Eastern Cooperative Oncology Group. Clin Breast Cancer. e-Pub 2013. PMID: 23816985.
- Cruciani RA, Zhang JJ, Manola J, Cella D, Ansari B, Fisch MJ. L-carnitine supplementation for the management of fatigue in patients with cancer: An Eastern Cooperative Oncology Group phase III, randomized, double-blind, placebo-controlled trial. J Clin Oncol 30(31):3864-9, 2012. PMID: 22987089.
- Dizon D, Graham D, Thompson M, Johnson L, Johnston C, Fisch M, Miller R. Practical guidance: The use of social media in oncology practice. J Oncol Pract 8(5):114-24, 2012. e-Pub 2012. PMID: 23277774.
- Hwang JP, Fisch MJ, Zhang H, Kallen MA, Routbort MJ, Lal L, Vierling JM, Suarez-Almazor ME. Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract 8(4):32-9, 2012. e-Pub 2012. PMID: 23180996.
- Lal LS, Zhuang A, Hung F, Feng C, Arbuckle R, Fisch MJ. Evaluation of drug interactions in patients treated with antidepressants at a tertiary care cancer center. Support Care Cancer 20(5):983-9, 2012. e-Pub 2011. PMID: 21519946.
- Fisch MJ, Lee JW, Weiss M, Wagner LI, Chang VT, Cella D, Manola JB, Minasian LM, McCaskill-Stevens W, Mendoza TR, Cleeland CS. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol, 2012. PMID: 22508819.
- Ritchie CS, Kvale E, Fisch MJ. Multimorbidity: an issue of growing importance for oncologists. J Oncol Pract 7(37):371-4, 2011. PMID: 22379419.
Editorials
- Fisch MJ, McNeill LH, Basen-Engquist KM. Helping colorectal cancer survivors benefit from changing lifestyle behaviors: implementation science and private industry collaboration to the rescue. JAMA Oncol 6(29801068):777-778, 2018.
- Elsyaem AF, Fisch MJ. Neuroleptics for delirium: More research is needed [letter]. JAMA Intern Med 7(28672353):177, 2017.
- Fisch MJ, Chang VT. Striving for Safe, Effective, Affordable Care for Cancer Survivors With Chronic Pain: Another Kind of Moonshot. JAMA Oncol(27054656), 2016.
- Fisch MJ. Advance directives: sometimes necessary but rarely sufficient. JAMA Oncol 5(26185151):609-610, 2015.
Abstracts
- Tevaarwerk AJ, Lee JW, Sesto ME, Buhr KA, Cleeland CS, Manola J, Wagner Ll, Chang VT, Fisch MJ. Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study. J Cancer Surviv 7(2):191-202, 2013. PMID: 23378060.
- Zhao F, Chang VT, Cleeland C, Cleary JF, Mitchell EP, Patterson E, Wagner LI, Fisch MJ. Determinants of pain changes in ambulatory cancer patients by baseline pain severity: An analysis from ECOG E2Z02 (SOAPP Study)(MASCC Annual Meeting). Support Care Cancer 20(S151), 2012. e-Pub 2012.
- Chang VT, Zhao F, Tevaarwerk A, Mitchell EP, Patterson E, Ritchie C, Manola J, Wagner LI, Fisch MJ. Determinants of driving in cancer patients: an analysis for SOAPP (ECOG E2Z02: Symptom Outcomes and Practice Patterns)(MASCC Annual Meeting). Support Care Cancer 20(S151), 2012.